Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for We Can Medicines Co., Ltd. (6929:TWSE), powered by AI.
We Can Medicines Co., Ltd. is currently trading at $24.50. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for We Can Medicines Co., Ltd. on Alpha Lenz.
View We Can Medicines Co., Ltd.'s valuation metrics on Alpha Lenz.
“We Can Medicines Co., Ltd.'s ROE is -6.8%. Explore profitability and growth together.”
Ask for details →We Can Medicines Co., Ltd. is a leading operator of chain cosmeceutical drugstores in Taiwan, recognized for its extensive retail network and comprehensive product portfolio. The company’s core operations encompass the sale of pharmaceuticals, health foods, medical supplies, and daily necessities, along with specialized offerings for maternal and infant care, beauty care, and home living needs. In addition to physical retail stores, it markets products under established brands and serves customers online. Headquartered in Taichung and employing over 1,000 people, We Can Medicines Co., Ltd. plays a pivotal role in Taiwan’s consumer staples sector, consistently delivering essential healthcare and lifestyle products to a broad customer base. The company generates most of its revenue domestically and is also involved in wholesale and import activities, broadening its presence within the wider healthcare and drug retail industry.
“We Can Medicines Co., Ltd.'s ROE is -6.8%. Explore profitability and growth together.”
Ask for details →We Can Medicines Co., Ltd. (ticker: 6929) is a company listed on TWSE in the Consumer Defensive sector (Packaged Foods). It has approximately 1,005 employees.
The current price is 24.5 with a P/E ratio of -x and P/B of -x.
ROE is -6.76% and operating margin is -2.10%. Annual revenue is $3.2B.